ADMA
ADMA Biologics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.62
+0.42%Leverage
- Debt / equity
- 0.50x
- Net debt / equity
- 0.17x
- Debt / assets
- 0.30x
- Debt / EBITDA
- 0.87x
- Net debt / EBITDA
- 0.29x
Liquidity & coverage
- Current ratio
- 6.97x
- Quick ratio
- 3.81x
- Cash ratio
- 1.80x
- Interest coverage
- 24.53x
- EBITDA / interest
- 26.61x
- Working capital
- $452.4M
Cash & dividend
- FCF / debt
- 0.57x
- Cash flow / debt
- 0.67x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026